{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T05:06:16Z","timestamp":1793423176702,"version":"4.5.0"},"reference-count":0,"publisher":"Informa UK Limited","license":[{"start":{"date-parts":[[2015,1,1]],"date-time":"2015-01-01T00:00:00Z","timestamp":1420070400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/3.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["TCRM"],"DOI":"10.2147\/tcrm.s55506","type":"journal-article","created":{"date-parts":[[2015,1,6]],"date-time":"2015-01-06T01:28:40Z","timestamp":1420507720000},"page":"63","source":"Crossref","is-referenced-by-count":15,"title":["Biologics in the management of ulcerative colitis – comparative safety and efficacy of TNF-α antagonists"],"prefix":"10.2147","author":[{"given":"Anita","family":"Afzali","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca","family":"Fausel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2015,1]]},"container-title":["Therapeutics and Clinical Risk Management"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.dovepress.com\/getfile.php?fileID=23093","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2016,10,30]],"date-time":"2016-10-30T22:17:33Z","timestamp":1477865853000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.dovepress.com\/biologics-in-the-management-of-ulcerative-colitis-ndash-comparative-sa-peer-reviewed-article-TCRM"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,1]]},"references-count":0,"URL":"https:\/\/doi.org\/10.2147\/tcrm.s55506","relation":{},"ISSN":["1178-203X"],"issn-type":[{"value":"1178-203X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,1]]}}}